Isotechnika Pharma Inc IPHAF

Perpetual disappointment

[blog]

It’s likely this is the best deal available, but I’m disappointed management couldn’t sell this company between $2 and $4 dollars as that seems reasonable. I hope Foster and the management team isn’t being deceitful or possibly delusional, by that I mean secretly trying to make this company into a big pharma company at our expense. Paladin’s plans for Isotechnika include making them a conduit for future drugs in their pipeline and of course Isotechnika will get their cut of the profits, sounds like that will take lots of money and time.

If you asked Foster about all this I imagine he would say something to the effect; at the end of it all, if it doesn’t work out, at least you’ll have me.